Detection and Analysis of Alzheimer's Disease from Medical Images: A Survey

Many detection methods for the identification of Alzheimer's disease (AD) had been proposed in the past several decades. As there is no heal for AD to reverse its advancement, it is of key significance for early diagnosis and supervising of AD at its early introductory stage, i.e., mild cognitive impairment (MCI). New applications and methodologies are required for analyzing and to provide immediate early stage treating. Different biomarkers and clinical signs are used to assess the progression of AD depending on the patient's condition and disease stage. The current technology aims to help the drug in the treatment and care of patients with symptoms and biological properties. These parameters will assist in prior medication, and prevention could be ascertained in order to prevent the disease in reaching further stages.